The state of disparities in opportunistic infection prophylaxis for blacks with HIV/AIDS.

Autor: Oramasionwu CU, Koeller JM, Lawson KA, Brown CM, Morse GD, Frei CR, Oramasionwu, Christine U, Koeller, Jim M, Lawson, Kenneth A, Brown, Carolyn M, Morse, Gene D, Frei, Christopher R

Publikováno v: Medical Care; 2012 Nov, Vol. 50 Issue 11, p920-927, 8p

PIN51 A PICTURE OF DEMOGRAPHIC DISPARITIES IN THE RECEIPT OF ANTIRETROVIRAL THERAPY AMONG HIV PATIENTS IN THE 2000-2005 NATIONAL AMBULATORY MEDICAL CARE SURVEYS (NAMCS)

Autor: Oramasionwu, CU, Ryan, L, Frei, CR

Publikováno v: In Value in Health 2008 11(3):A108-A108

An Electronic Health Record-Based Strategy to Systematically Assess Medication Use Among Primary Care Patients With Multidrug Regimens: Feasibility Study.

Autor: Bailey SC; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Oramasionwu CU; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Infanzon AC; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Pfaff ER; North Carolina Translational and Clinical Sciences Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Annis IE; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Reuland DS; Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2017 Aug 10; Vol. 6 (8), pp. e157. Date of Electronic Publication: 2017 Aug 10.

Corrigendum to "The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care" [Contemp. Clin. Trials (2016) 72-77].

Autor: Bailey SC; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States. Electronic address: scbailey@unc.edu., Paasche-Orlow MK; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, United States., Adams WG; Department of Pediatrics, Boston University School of Medicine, Boston, MA, United States., Brokenshire SA; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States., Hedlund LA; Health Literacy and Learning Program, Division of General Internal Medicine & Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Hickson RP; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States., Oramasionwu CU; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, United States., Moore AL; Health Literacy and Learning Program, Division of General Internal Medicine & Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., McCarthy DM; Department of Emergency Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Curtis LM; Health Literacy and Learning Program, Division of General Internal Medicine & Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Kwasny MJ; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Wolf MS; Health Literacy and Learning Program, Division of General Internal Medicine & Geriatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Publikováno v: Contemporary clinical trials [Contemp Clin Trials] 2017 Jun; Vol. 57, pp. 99. Date of Electronic Publication: 2017 Mar 17.

Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy.

Autor: Roberts AW; Andrew W. Roberts (drewroberts1@creighton.edu) is an assistant professor in the Department of Pharmacy Sciences, School of Pharmacy and Health Professions, and a program faculty member in the Center for Health Services Research and Patient Safety, both at Creighton University, in Omaha, Nebraska., Farley JF; Joel F. Farley is a professor in the Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, at the University of North Carolina at Chapel Hill., Holmes GM; G. Mark Holmes is an associate professor in the Department of Health Policy and Management, Gillings School of Global Public Health, and director of the the Cecil G. Sheps Center for Health Services Research, both at UNC-Chapel Hill., Oramasionwu CU; Christine U. Oramasionwu is an assistant professor in the Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, at UNC-Chapel Hill., Ringwalt C; Chris Ringwalt is a senior research scientist at the Injury Prevention Research Center, UNC-Chapel Hill., Sleath B; Betsy Sleath is the George H. Cocolas Distinguished Professor; chair of the Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy; and director of the Child and Adolescent Health Services Program at the Sheps Center, all at UNC-Chapel Hill., Skinner AC; Asheley C. Skinner is an associate professor at the Duke Clinical Research Institute, Duke University, in Durham, North Carolina.

Publikováno v: Health affairs (Project Hope) [Health Aff (Millwood)] 2016 Oct 01; Vol. 35 (10), pp. 1884-1892.